/Companies

Centivax

37 employees on LinkedIn · 6 known investors

Find your way into Centivax

Sign up to see every warm intro you have to Centivax

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Centivax team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.

Founders & leadership

JGJacob Glanville
Jacob GlanvilleFounder, CEO & PresidentJacob Glanville is a computational immunologist and the founder and CEO of Centivax, a biotechnology company developing broad-spectrum vaccines and antibody therapeutics, including a universal influenza vaccine. He previously founded the antibody engineering company Distributed Bio, which was acquired in 2020.
SWStephanie Wisner
Stephanie WisnerCo-Founder, Treasurer, Chief Business OfficerFounder of Centivax, a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine. She authored a book on biotech entrepreneurship, "Building Backwards to Biotech," aimed at introducing readers to the biotech industry.

Investors · 6

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

Companies working in the same space as Centivax.

In the news

Frequently asked questions

What does Centivax do?
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Who founded Centivax?
Centivax was founded by Jacob Glanville, Stephanie Wisner.
Who are Centivax's investors?
Centivax's investors include Amplify Partners, Bold Capital Partners, Future Ventures, Global Health Investment Corporation, Kendall Capital Partners, NFX.